COVID-19

12/03/2020

EuBiologics partners up with IVI in COVID-19 vaccine development

December 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) and EuBiologics exchanged an MOU to cooperate in clinical development of the COVID-19 vaccine the company is currently developing. The signing ceremony at IVI headquarters on December 2 was attended by Dr. Jerome […]
01/20/2021

Leading experts suggest comprehensive post-efficacy strategy required after demonstrated efficacy of COVID-19 vaccines in Nature Medicine commentary

01/22/2021

CNN | “Our response needs to be clear, strong, and unified”

01/25/2021

DEVEX | Opinion: COVAX — too big, and too important, to fail

DONATE